Skip to main content
F1000Research logoLink to F1000Research
. 2016 Mar 24;5:F1000 Faculty Rev-396. [Version 1] doi: 10.12688/f1000research.7432.1

Extremophiles and biotechnology: current uses and prospects

James A Coker 1,a
PMCID: PMC4806705  PMID: 27019700

Abstract

Biotechnology has almost unlimited potential to change our lives in very exciting ways. Many of the chemical reactions that produce these products can be fully optimized by performing them at extremes of temperature, pressure, salinity, and pH for efficient and cost-effective outcomes. Fortunately, there are many organisms (extremophiles) that thrive in extreme environments found in nature and offer an excellent source of replacement enzymes in lieu of mesophilic ones currently used in these processes. In this review, I discuss the current uses and some potential new applications of extremophiles and their products, including enzymes, in biotechnology.

Keywords: Extremophiles, Biotechnology, biofuels, Carotenoids, Proteases, Lipases

Introduction

The impact of biotechnology on our lives is inescapable. Some of these impacts are well publicized, like the process of generating biofuels. However, there are numerous other applications that are not widely known outside of specialist circles that affect our daily life, such as food and drink (e.g. lactose-free milk 1 and bioinsecticides 2), how we make and wash our clothes (e.g. cellulases to produce ‘stone-washed’ jeans 3, lipases 4, and proteases 5 in detergents), and the medications we take to remain healthy, just to name a few examples.

Many of the reactions performed in the process of making these products are often not optimized because mesophilic enzymes are used at extremes of temperature, pressure, salinity, and pH 6. The efficiency of these enzymes is often improved through genetic and/or chemical modification 7, 8 as well as immobilization strategies 9, all of which are designed to produce biocatalysts with improved properties such as increased activity and/or stability to use in specific industrial processes. This can be a lengthy and (more importantly) costly enterprise, especially since nature provides many readily available alternatives in the form of extremozymes, which are found in organisms that thrive in extremes of temperature (as high as 122°C and as low as −12°C), pressure (as high as 1000 atm), salinity (up to and including saturating levels), and pH (from 0 to 6 and 8 to 12) 1015. As such, their enzymes are already adapted to work under the extreme conditions of many industrial processes.

To date, few extremophiles/extremozymes have found their way into large-scale use in the field of biotechnology 16; however, their potential is undeniable in many applications. Four success stories are the thermostable DNA polymerases used in the polymerase chain reaction (PCR) 17, various enzymes used in the process of making biofuels 18, organisms used in the mining process 19, and carotenoids used in the food and cosmetic industries 20. Other potential applications include making lactose-free milk 1; the production of antibiotics, anticancer, and antifungal drugs 6; and the production of electricity or, more accurately, the leaching of electrons to generate current that can be used or stored 21.

This review initially focuses on the four success stories of extremozymes in biotechnology. Then it discusses the most prominent sectors of the enzyme market (glycosyl hydrolases, lipases, proteases, and those of medical importance) where the application of extremophiles/extremozymes could replace currently used enzymes to make reactions more efficient and/or cost effective.

DNA polymerases

It is difficult to overstate the success or impact the DNA polymerases from the thermophiles Thermus aquaticus, Pyrococcus furiosus, and Thermococcus litoralis, otherwise known as Taq 22, Pfu 23, and Vent 24, respectively, have had in biotechnology. Without a doubt, the automated version of the PCR would not have been possible without these enzymes. During its patent lifetime, PCR earned its rights holders over $2 billion in royalties 25. It is difficult to imagine our lives without PCR, especially for a typical bench scientist. However, fields once thought to be far removed from science, like law enforcement, have also benefitted greatly from PCR by making it more readily possible to identify and rule out suspects on the basis of their DNA profile 26. Even the entertainment industry, with its many movies, novels, and TV shows centered on forensic science and PCR-based technologies, has greatly benefitted from PCR. The impact these three hyperthermophilic enzymes have had on biotechnology and our current culture can only be described as immense.

Biofuel production

In an effort to supplement the planet’s dwindling supply of fossil fuels, there has been a concerted effort to generate similar fuels using biomass (e.g. corn, beets, wheat, and sugar cane). Depending on the specific source, biofuels can be categorized into first and second generation. First-generation biofuels are those derived from the ‘easily’ hydrolyzed sugars, starches, and oils of available crops, whereas second-generation biofuels are derived from lignocellulosic material, which is more resistant to hydrolysis.

Biofuels can also be categorized by the eventual end products: butanol, ethanol, hydrogen, methane, and biodiesel. Traditional methods of biobutanol and bioethanol production involve the use of a chemical process supplemented with the use of mesophilic microorganisms such as Saccharomyces cerevisiae and Clostridium species 27. The production of hydrogen traditionally relies on a chemical/catalyst process 28; however, larger-scale microorganism-based systems using the thermophiles Caldicellulosiruptor saccharolyticus and Thermotoga elfii have been developed recently 29. In contrast to the other products, methane has always been produced using a consortium of microorganisms, which include methanogens (extremophiles that are the only known biologic producers of methane) 18.

Many of the steps in biofuel production involve high temperatures and extremes of pH; therefore, extremophiles are ideal candidates to replace the mesophilic organisms used in traditional methods. For example, Thermoanaerobacterium saccharolyticum is able to utilize hemicellulose and pentose sugars like xylose as a starting material to produce ethanol 30. Engineered versions of this thermophile have shown great promise in producing large quantities of ethanol and minimizing other side reactions/products 31. There are also numerous applications for extremophiles in the production of hydrogen through anaerobic fermentation and hydrogenases. The use of strains of Caldicellulosiruptor, Thermoanaerobacterium 32, Pyrococcus 33, and Aeropyrum 34 shows immense potential. The research is still very preliminary; however, recent advances such as the engineering of a hyperthermophile are quite promising 35, 36.

The two products produced by microorganisms that show the most commercial success are biodiesel and butanol. Biodiesel harvests the power of high lipid content (>75% dry weight) algae, most of which contain long-chain hydrocarbons like those found in petroleum. There are several extremophilic algae (e.g. Cyanidium caldarium 37 and Galdieria sulphuraria 38) that meet these requirements. Engineered halophilic algae also hold great promise, as they can be grown in open containers since the high salinity required for their growth inhibits other microbes. This means they can be grown in underutilized environments such as the oceans and arid/desert environments 39.

Butanol is quite inhibiting to the growth of microorganisms compared with ethanol (most organisms cannot tolerate more than 2%). As such, organisms need to be modified in order to overcome product inhibition and withstand large quantities of butanol. Currently, Green Biologics is producing biobutanol from corn stock by using thermophilic Clostridium. Other companies such as Gevo, Joule Unlimited, and Solazyme are also able to produce large-scale volumes of bioethanol and biodiesel as well as jet fuel for both civilian and military use. Additionally, Sapphire Energy has moved one step back in the process and generates what it calls ‘Green Crude’, which can act as a replacement for crude oil in the existing petroleum infrastructure.

Biomining

In addition to biofuels, another important application of extremophiles and their enzymes can be found in the mining sector 40. This process, also known as bioleaching, is the removal of insoluble metal sulfides or oxides by using microorganisms 41. It is a safer and more environmentally friendly way to extract metals compared with traditional heap leaching, which involves the use of several chemicals, including cyanide, to bind and separate specific minerals/metals from others.

In 1992, biomining accounted for 10% of worldwide copper production 6, but current estimates place it at around 15% for copper and 5% for gold 42. Extraction rates are around 90% from biomining compared with 60% for traditional heap leaching 41. Biomining techniques have successfully been employed to mine metals such as gold, silver, copper, zinc, nickel, and uranium. The organisms used in this process are acidophiles such as Acidithiobacillus and Ferroplasma. However, depending on the conditions, more thermophilic strains, like Sulfolobus and Metallosphaera 40, 41, may have to be employed.

Although biomining is generally safe, it does need to be tightly controlled, since it can result in acid mine drainage (AMD), which occurs when acidic water, generated by the oxidation of sulfides from the mine, begins flowing or leaching out of the mine. Since the acidophiles employed in biomining thrive in acidic and usually heavy-metal environments, AMD results in an environment that is not only very acidic but also rich in heavy metals. Copper, zinc, and nickel mines are the most common sources of AMD 41. Interestingly, mesophilic and sometimes psychrophilic acidophiles are the main culprits of AMD 41. However, when thermophiles are used in biomining, the possibilities of AMD are reduced and costs associated with the cooling of processing tanks are kept to a minimum.

Carotenoids

Carotenoids are natural pigments and in extremophiles are most often associated with the halophilic archaea and algae 43. Most carotenoids cannot be synthesized/extracted from organisms at levels that are useful for industry; however, there are three exceptions to this: bacteriorhodopsin, canthaxanthin, and β-carotene 44.

Bacteriorhodopsin is a membrane-bound retinal pigment as well as a proton pump that functions as a rudimentary form of photosynthesis. It is a very stable molecule and harvested from the extreme halophilic archaeon Halobacterium salinarum 43. It has been adapted for use in a wide range of applications from holography, artificial retinas, photochromic dyes, spatial light modulators, and the renewal of biochemical energy 45.

Canthaxanthin is a lipid-soluble antioxidant used as a food dye and a feed additive. As a feed additive, it is used in fish, crustacean, and poultry farms. It is also used in the cosmetics industry and usually is the primary ingredient in tanning pills 46. As with bacteriorhodopsin, halophilic archaea are the producers of choice with Haloferax alexandrinus being the preferred strain 47.

β-carotene is a red/orange pigment and the primary colorant in carrots, pumpkins, and halophilic microorganisms. The halophilic alga Dunaliella salina is the major source for β-carotene, as its commercial-scale growth results in 30–40 g dry weight/m 2 per day 39. Due to its chemical nature, it is a lipid/oil- and water-soluble molecule, which makes it excellent as an additive in the baking process (e.g. food coloring) and emulsions (e.g. confectionery and prepared foods). However, its primary use is probably as a food supplement 39.

Proteases/lipases

Proteases and lipases, combined with the gylcosyl hydrolases, account for more than 70% of all enzymes sold 48 while proteases alone are the most widely used class of enzyme. Proteases have numerous applications in diverse fields; however, the largest application is in laundry detergents, where they have been a standard component since 1985 and are used to break apart and remove protein-based stains 49. The other major uses for proteases are in the fields of cheese making, brewing, and baking. Typically, the microbial proteases used are mesophilic and derived from Bacillus species and produced by companies such as Novozymes and Genencor. However, explorations using psychrophilic proteases to enhance cold water washing have taken place. Unfortunately, most psychrophilic enzymes have proven to be unusable due to low stability at room temperature. However, through directed evolution, a chimeric psychrophilic/mesophilic protease was generated that improved performance during cold water washing 50.

Lipases are a billion-dollar industry 51 and very attractive for use in industrial settings because of their broad range of substrates, high degree of specificity, and stability 52. Although their applications in laundry detergents (i.e. low temperatures and alkaline conditions) and organic synthesis (i.e. low water activity) require lipases to be active under extreme conditions, most lipases used are mesophilic. Many mesophilic lipases, which typically come from organisms like Bacillus and Aspergillus species, are active at high temperatures. As a result, extremophilic lipases are often overlooked; however, lipases from thermophilic Bacillus species have been shown to be more efficient than currently used enzymes 53.

Glycosyl hydrolases and sugars

Glycosyl hydrolases hydrolyze the glycosidic bond between a carbohydrate and another moiety and are categorized into well over 100 families. The hydrolysis generally takes place with the use of only two amino acids—a proton donor and a nucleophile/base—and results in retention or inversion of the anomeric configuration of the resulting carbohydrate.

Roughly 70% of the world’s population 54 suffers from lactose intolerance resulting from a lack or loss of β-galactosidase activity. For this majority of the population, the best way to avoid the often embarrassing symptoms of lactose intolerance is through the consumption of lactose-free milk and other dairy products, which are generated via the use of the lactase (β-galactosidase) from organisms like Kluyveromyces lactis 54. However, for the enzyme to be active, the temperature of the dairy product must be raised (from about 5°C to 25°C). This elevation in temperature creates the potential for pathogens to grow as well as for altering the flavor profile of the milk. A simple solution to both issues is to use a β-galactosidase from a psychrophile 1. This enzyme would be active at low temperature and hydrolyze lactose throughout the entire process from production to shipment and storage by the consumer 55. This approach could save significant amounts of money by eliminating the heating step as well as achieve a high percentage of lactose hydrolysis. Currently, several cold-adapted enzymes have been characterized and developed that perform on par with the currently used mesophilic enzymes when compared at their respective temperature optima (i.e. 15°C and 37°C) 1, 55, 56.

Similar to the industrial-scale hydrolysis of lactose, that of starch traditionally uses mesophilic enzymes. Starch-hydrolyzing enzymes comprise about 25% of the worldwide enzyme market; however, several adjustments in temperature and pH are needed for most of the reactions to ensure optimal conditions.

Since the industrial processes involved in hydrolyzing starch require high temperatures (95°C for one step and 60°C for the other) and high pH, polyextremophilic (thermophilic and alkaliphilic) enzymes would be ideal. Currently, an α-amylase from Bacillus acidicola 57, glucoamylases from Picrophilus 58, and a pullulanase from Thermococcus kodakarensis 59 show great promise in replacing their mesophilic counterparts. However, amylases have also been isolated from halophiles, such as Halomonas meridian and Natronococcus amylolyticus, that could be useful in the process of producing high-fructose corn syrup, which is produced by hydrolyzing corn starch 43.

In addition to sugar hydrolysis, another promising application for extremophiles is the production of carbohydrates like trehalose and ectoine, which can be used as stabilizers for products like antibodies and vaccines 60, 61. The production of trehalose from Sulfolobus solfataricus in a bioreactor has been perfected and could easily replace the currently used mesophilic enzymes from Arthrobacter species Q36 43. Another example is ectoine, which has been shown to protect skin from UVA-induced damage. RonaCare™ Ectoin, produced by Merck KGaA (Darmstadt, Germany) is used as a moisturizer and comes from halophilic microorganisms 39. In addition to trehalose and ectoine, several other carbohydrates are produced by halophiles as compatible solutes that can also be employed as preservatives 62.

Medical applications

Surprisingly, microorganisms, including extremophiles, are producers of a host of antibiotics, antifungals, and antitumor molecules 63. In truth, this should come as little surprise, as microorganisms have been killing each other and fighting for survival for billions of years. After that long a time, it should be clear that microorganisms have perfected the art of warfare, but it is up to us to take advantage of it.

In addition to the typical antibiotics known from mesophilic microorganisms 64, 65, extremophiles are known to generate antimicrobial peptides and diketopiperazines 66. Antimicrobial peptides have been found in the Halobacteriaceae (phylogenetic family containing all halophilic archaea) as well as Sulfolobus species. These peptides (halocins) from halophilic archaea are thought to be found in all species of the family. Each halocin has a specific range of activity, and some act on a broader range of microorganisms than others 39. Halocins have been shown to be effective at killing archaeal cells; however, there are no data to show that halocins kill microorganisms pathogenic to humans. Interestingly, there is evidence that they assist canines in recovering from surgery 67.

Diketopiperazines (also known as cyclic dipeptides) have been shown to affect blood-clotting functions as well as having antimicrobial, antifungal, antiviral, and antitumor properties. They are found in halophiles like Naloterrigena hispanica and Natronococcus occultus 45 and have been shown to activate and inhibit quorum-sensing pathways 66. These pathways are important in pathogens such as Pseudomonas aeruginosa, which is one of the causative agents of pneumonia and a typical infection found in patients with cystic fibrosis 68, 69. Therefore, this could be an alternative treatment for the tens of thousands of drug-resistant Pseudomonas aeruginosa infections that occur each year ( http://www.cdc.gov/hai/organisms/pseudomonas.html).

In addition to molecules that kill other organisms and tissues, extremophiles can also play a role in the medical field through the use of bioplastics. Several species of extremophiles produce polyhydroxyalkanoates (PHAs), which are a heterogeneous group of polyesters; however, they are most commonly found in the halophilic archaea 39. For example, it has been shown that Haloferax medeterrani can be grown with 65% of its dry weight as PHAs, which translates into 6 g/L of culture when grown in media supplemented with starch 45. PHAs are often used as carbon storage for microbial cells but have been harnessed to generate bioplastics and have been lauded for their biocompatibility, resistance to water, and biodegrading properties, all of which make them an attractive alternative to petroleum-based plastics 45.

Finally, a very interesting extremophile contribution to the field of medicine comes in the form of an alternative vaccine delivery system 70. Several microorganisms produce internal gas vesicles, small gas-filled proteinaceous structures, the best-studied coming from the halophilic archaea. These structures have been engineered in Halobacterium species NRC-1 to generate a recombinant form that expresses portions of the simian immunodeficiency virus on the external surface 71. Once collected, these recombinant vesicles have shown a strong antibody response and immune memory when injected into mice. Typically, vaccines derived from recombinant methods require the addition of adjuvants (e.g. cholera toxin B) to elicit a large enough immune response 71. However, in the case of the recombinant gas vesicles from Halobacterium species NRC-1, the organism’s own polar lipids can be used as an adjuvant, as they raise a large immune response since they are ether linked as opposed to the more typical ester-linked molecules. Experiments using NRC-1’s polar lipids and recombinant gas vesicles as a nasal-delivered vaccine in mice were quite encouraging and showed no toxicity 71.

Conclusions

With established commercial success in the DNA polymerase, biofuels, biomining, and carotenoid sectors of biotechnology, extremophiles and their enzymes have an extensive foothold in the market that is expected to keep growing. However, to fulfill this great potential, innovative methods will have to be developed to overcome current roadblocks. The most significant is a current lack of ability to produce most extremophiles/extremozymes on the large scale required by industrial processes. Some recombinant extremozymes can be produced in large quantities by mesophilic organisms like Escherichia coli; however, this is not true for most. Therefore, new expression systems will have to be developed with extremophilic organisms as the host to achieve high expression of soluble proteins. Another significant roadblock is the general lack of partnerships among academia, industry, and government. More opportunities for ties between all three groups should be encouraged, nurtured, and supported from all sides. For it is only with all three working together that the most progress will be made.

Abbreviations

AMD, acid mine drainage; PCR, polymerase chain reaction; PHA, polyhydroxyalkanoate.

Acknowledgments

I would like to thank all of my students and members of my laboratory as well as my colleagues for the discussions we have had over the years. I have learned a lot from you all and look forward to many more years of the same.

Editorial Note on the Review Process

F1000 Faculty Reviews are commissioned from members of the prestigious F1000 Faculty and are edited as a service to readers. In order to make these reviews as comprehensive and accessible as possible, the referees provide input before publication and only the final, revised version is published. The referees who approved the final version are listed with their names and affiliations but without their reports on earlier versions (any comments will already have been addressed in the published version).

The referees who approved this article are:

  • Melanie Mormile, Department of Biological Sciences, Missouri University of Science and Technology, Rolla, MO, USA

  • Khawar Sohail Siddiqui, School of Biotechnology and Biomolecular Sciences, The University of New South Wales, Sydney, Australia

Funding Statement

The author(s) declared that no grants were involved in supporting this work.

[version 1; referees: 2 approved]

References

  • 1. Coker JA, Brenchley JE: Protein engineering of a cold-active beta-galactosidase from Arthrobacter sp. SB to increase lactose hydrolysis reveals new sites affecting low temperature activity. Extremophiles. 2006;10(6):515–24. 10.1007/s00792-006-0526-z [DOI] [PubMed] [Google Scholar]
  • 2. Rubio-Infante N, Moreno-Fierros L: An overview of the safety and biological effects of Bacillus thuringiensis Cry toxins in mammals. J Appl Toxicol. 2015. 10.1002/jat.3252 [DOI] [PubMed] [Google Scholar]
  • 3. Miettinen-Oinonen A, Suominen P: Enhanced production of Trichoderma reesei endoglucanases and use of the new cellulase preparations in producing the stonewashed effect on denim fabric. Appl Environ Microbiol. 2002;68(8):3956–64. 10.1128/AEM.68.8.3956-3964.2002 [DOI] [PMC free article] [PubMed] [Google Scholar]; F1000 Recommendation
  • 4. Joseph B, Ramteke PW, Thomas G: Cold active microbial lipases: some hot issues and recent developments. Biotechnol Adv. 2008;26(5):457–70. 10.1016/j.biotechadv.2008.05.003 [DOI] [PubMed] [Google Scholar]
  • 5. Joshi S, Satyanarayana T: Biotechnology of cold-active proteases. Biology (Basel). 2013;2(2):755–83. 10.3390/biology2020755 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Herbert RA: A perspective on the biotechnological potential of extremophiles. Trends Biotechnol. 1992;10(11):395–402. 10.1016/0167-7799(92)90282-Z [DOI] [PubMed] [Google Scholar]
  • 7. Gatti-Lafranconi P, Natalello A, Rehm S, et al. : Evolution of stability in a cold-active enzyme elicits specificity relaxation and highlights substrate-related effects on temperature adaptation. J Mol Biol. 2010;395(1):155–66. 10.1016/j.jmb.2009.10.026 [DOI] [PubMed] [Google Scholar]; F1000 Recommendation
  • 8. Siddiqui KS, Parkin DM, Curmi PM, et al. : A novel approach for enhancing the catalytic efficiency of a protease at low temperature: reduction in substrate inhibition by chemical modification. Biotechnol Bioeng. 2009;103(4):676–86. 10.1002/bit.22300 [DOI] [PubMed] [Google Scholar]; F1000 Recommendation
  • 9. Mukhopadhyay A, Dasgupta AK, Chakrabarti K: Enhanced functionality and stabilization of a cold active laccase using nanotechnology based activation-immobilization. Bioresour Technol. 2015;179:573–84. 10.1016/j.biortech.2014.12.070 [DOI] [PubMed] [Google Scholar]; F1000 Recommendation
  • 10. Auman AJ, Breezee JL, Gosink JJ, et al. : Psychromonas ingrahamii sp. nov., a novel gas vacuolate, psychrophilic bacterium isolated from Arctic polar sea ice. Int J Syst Evol Microbiol. 2006;56(Pt 5):1001–7. 10.1099/ijs.0.64068-0 [DOI] [PubMed] [Google Scholar]; F1000 Recommendation
  • 11. Horikoshi K: Alkaliphiles: some applications of their products for biotechnology. Microbiol Mol Biol Rev. 1999;63(4):735–50, table of contents. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Kato C, Li L, Nogi Y, et al. : Extremely barophilic bacteria isolated from the Mariana Trench, Challenger Deep, at a depth of 11,000 meters. Appl Environ Microbiol. 1998;64(4):1510–3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Takai K, Nakamura K, Toki T, et al. : Cell proliferation at 122 degrees C and isotopically heavy CH 4 production by a hyperthermophilic methanogen under high-pressure cultivation. Proc Natl Acad Sci U S A. 2008;105(31):10949–54. 10.1073/pnas.0712334105 [DOI] [PMC free article] [PubMed] [Google Scholar]; F1000 Recommendation
  • 14. Moran-Reyna A, Coker JA: The effects of extremes of pH on the growth and transcriptomic profiles of three haloarchaea [version 1; referees: 2 approved, 1 approved with reservations]. F1000Res. 2014;3:168. 10.12688/f1000research.4789.2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Johnson DB, Kanao T, Hedrich S: Redox Transformations of Iron at Extremely Low pH: Fundamental and Applied Aspects. Front Microbiol. 2012;3:96. 10.3389/fmicb.2012.00096 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Elleuche S, Schröder C, Sahm K, et al. : Extremozymes--biocatalysts with unique properties from extremophilic microorganisms. Curr Opin Biotechnol. 2014;29:116–23. 10.1016/j.copbio.2014.04.003 [DOI] [PubMed] [Google Scholar]
  • 17. Ishino S, Ishino Y: DNA polymerases as useful reagents for biotechnology - the history of developmental research in the field. Front Microbiol. 2014;5:465. 10.3389/fmicb.2014.00465 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Barnard D, Casanueva A, Tuffin M, et al. : Extremophiles in biofuel synthesis. Environ Technol. 2010;31(8–9):871–88. 10.1080/09593331003710236 [DOI] [PubMed] [Google Scholar]
  • 19. Johnson DB: Biomining-biotechnologies for extracting and recovering metals from ores and waste materials. Curr Opin Biotechnol. 2014;30:24–31. 10.1016/j.copbio.2014.04.008 [DOI] [PubMed] [Google Scholar]
  • 20. Oren A: Industrial and environmental applications of halophilic microorganisms. Environ Technol. 2010;31(8–9):825–34. 10.1080/09593330903370026 [DOI] [PubMed] [Google Scholar]
  • 21. Dopson M, Ni G, Sleutels TH: Possibilities for extremophilic microorganisms in microbial electrochemical systems. FEMS Microbiol Rev. 2016;40(2):164–81. 10.1093/femsre/fuv044 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Tindall KR, Kunkel TA: Fidelity of DNA synthesis by the Thermus aquaticus DNA polymerase. Biochemistry. 1988;27(16):6008–13. 10.1021/bi00416a027 [DOI] [PubMed] [Google Scholar]
  • 23. Lundberg KS, Shoemaker DD, Adams MW, et al. : High-fidelity amplification using a thermostable DNA polymerase isolated from Pyrococcus furiosus. Gene. 1991;108(1):1–6. 10.1016/0378-1119(91)90480-Y [DOI] [PubMed] [Google Scholar]
  • 24. Mattila P, Korpela J, Tenkanen T, et al. : Fidelity of DNA synthesis by the Thermococcus litoralis DNA polymerase--an extremely heat stable enzyme with proofreading activity. Nucleic Acids Res. 1991;19(18):4967–73. 10.1093/nar/19.18.4967 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Fore J, Jr, Wiechers IR, Cook-Deegan R: The effects of business practices, licensing, and intellectual property on development and dissemination of the polymerase chain reaction: case study. J Biomed Discov Collab. 2006;1:7. 10.1186/1747-5333-1-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Gurvitz A, Lai LY, Neilan BA: Exploiting biological materials in forensic science. Australas Biotechnol. 1994;4(2):88–91. [PubMed] [Google Scholar]
  • 27. Lee SY, Park JH, Jang SH, et al. : Fermentative butanol production by Clostridia. Biotechnol Bioeng. 2008;101(2):209–28. 10.1002/bit.22003 [DOI] [PubMed] [Google Scholar]
  • 28. Das D, Veziroglu TN: Hydrogen production by biological processes. A survey of literature. Int J Hydrogen Energy. 2001;26(1):13–28. 10.1016/S0360-3199(00)00058-6 [DOI] [Google Scholar]
  • 29. de Vrije T, de Haas GG, Tan GB, et al. : Pretreatment of Miscanthus for hydrogen production by Thermotoga elfii. Int J Hydrogen Energy. 2002;27(11–12):1381–90. 10.1016/S0360-3199(02)00124-6 [DOI] [Google Scholar]; F1000 Recommendation
  • 30. Demain AL, Newcomb M, Wu JH: Cellulase, clostridia, and ethanol. Microbiol Mol Biol Rev. 2005;69(1):124–54. 10.1128/MMBR.69.1.124-154.2005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Basen M, Schut GJ, Nguyen DM, et al. : Single gene insertion drives bioalcohol production by a thermophilic archaeon. Proc Natl Acad Sci U S A. 2014;111(49):17618–23. 10.1073/pnas.1413789111 [DOI] [PMC free article] [PubMed] [Google Scholar]; F1000 Recommendation
  • 32. Ren N, Cao G, Wang A, et al. : Dark fermentation of xylose and glucose mix using isolated Thermoanaerobacterium thermosaccharolyticum W16. Int J Hydrogen Energy. 2008;33(21):6124–32. 10.1016/j.ijhydene.2008.07.107 [DOI] [Google Scholar]; F1000 Recommendation
  • 33. Baker SE, Hopkins RC, Blanchette CD, et al. : Hydrogen production by a hyperthermophilic membrane-bound hydrogenase in water-soluble nanolipoprotein particles. J Am Chem Soc. 2009;131(22):7508–9. 10.1021/ja809251f [DOI] [PubMed] [Google Scholar]; F1000 Recommendation
  • 34. Nishimura H, Sako Y: Purification and characterization of the oxygen-thermostable hydrogenase from the aerobic hyperthermophilic archaeon Aeropyrum camini. J Biosci Bioeng. 2009;108(4):299–303. 10.1016/j.jbiosc.2009.04.017 [DOI] [PubMed] [Google Scholar]; F1000 Recommendation
  • 35. Lipscomb GL, Schut GJ, Thorgersen MP, et al. : Engineering hydrogen gas production from formate in a hyperthermophile by heterologous production of an 18-subunit membrane-bound complex. J Biol Chem. 2014;289(5):2873–9. 10.1074/jbc.M113.530725 [DOI] [PMC free article] [PubMed] [Google Scholar]; F1000 Recommendation
  • 36. Antoni D, Zverlov VV, Schwarz WH: Biofuels from microbes. Appl Microbiol Biotechnol. 2007;77(1):23–35. 10.1007/s00253-007-1163-x [DOI] [PubMed] [Google Scholar]
  • 37. Luca PD, Musacchio A, Taddei R: Acidophilic algae from the fumaroles of Mount Lawu (Java, locus classicus of Cyanidium caldarium Geitler. G Bot Ital. 1981;115(1):1–9. 10.1080/11263508109427979 [DOI] [Google Scholar]
  • 38. Pulz O, Gross W: Valuable products from biotechnology of microalgae. Appl Microbiol Biotechnol. 2004;65(6):635–48. 10.1007/s00253-004-1647-x [DOI] [PubMed] [Google Scholar]
  • 39. DasSarma P, Coker JA, Huse V, et al. : Halophiles, Industrial Applications. In: Encyclopedia of Industrial Biotechnology Hoboken, NJ, USA: John Wiley & Sons, Inc.2009. 10.1002/9780470054581.eib439 [DOI] [Google Scholar]
  • 40. Podar M, Reysenbach AL: New opportunities revealed by biotechnological explorations of extremophiles. Curr Opin Biotechnol. 2006;17(3):250–5. 10.1016/j.copbio.2006.05.002 [DOI] [PubMed] [Google Scholar]
  • 41. Vera M, Schippers A, Sand W: Progress in bioleaching: fundamentals and mechanisms of bacterial metal sulfide oxidation--part A. Appl Microbiol Biotechnol. 2013;97(17):7529–41. 10.1007/s00253-013-4954-2 [DOI] [PubMed] [Google Scholar]
  • 42. Everts S: Mining with microbes. Chem Eng News. 2012;90(42):34–5. Reference Source [Google Scholar]
  • 43. Schiraldi C, Giuliano M, De Rosa M: Perspectives on biotechnological applications of archaea. Archaea. 2002;1(2):75–86. 10.1155/2002/436561 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. Chandi GK, Gill BS: Production and Characterization of Microbial Carotenoids as an Alternative to Synthetic Colors: A Review. Int J Food Prop. 2011;14(3):503–13. 10.1080/10942910903256956 [DOI] [Google Scholar]
  • 45. Charlesworth JC, Burns BP: Untapped Resources: Biotechnological Potential of Peptides and Secondary Metabolites in Archaea. Archaea. 2015;2015: 282035. 10.1155/2015/282035 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46. Saito M, Koyano T, Miyamoto H, et al. : ATP synthesizing device.1992. [Google Scholar]
  • 47. Asker D, Ohta Y: Production of canthaxanthin by Haloferax alexandrinus under non-aseptic conditions and a simple, rapid method for its extraction. Appl Microbiol Biotechnol. 2002;58(6):743–50. 10.1007/s00253-002-0967-y [DOI] [PubMed] [Google Scholar]; F1000 Recommendation
  • 48. Li S, Yang X, Yang S, et al. : Technology prospecting on enzymes: application, marketing and engineering. Comput Struct Biotechnol J. 2012;2:e201209017. 10.5936/csbj.201209017 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49. Vojcic L, Pitzler C, Körfer G, et al. : Advances in protease engineering for laundry detergents. N Biotechnol. 2015;32(6):629–34. 10.1016/j.nbt.2014.12.010 [DOI] [PubMed] [Google Scholar]
  • 50. Tindbaek N, Svendsen A, Oestergaard PR, et al. : Engineering a substrate-specific cold-adapted subtilisin. Protein Eng Des Sel. 2004;17(2):149–56. 10.1093/protein/gzh019 [DOI] [PubMed] [Google Scholar]; F1000 Recommendation
  • 51. Jaeger KE, Dijkstra BW, Reetz MT: Bacterial biocatalysts: molecular biology, three-dimensional structures, and biotechnological applications of lipases. Annu Rev Microbiol. 1999;53:315–51. 10.1146/annurev.micro.53.1.315 [DOI] [PubMed] [Google Scholar]
  • 52. Hasan F, Shah AA, Hameed A: Industrial applications of microbial lipases. Enzyme Microb Technol. 2006;39(2):235–51. 10.1016/j.enzmictec.2005.10.016 [DOI] [Google Scholar]
  • 53. Imamura S, Kitaura S: Purification and characterization of a monoacylglycerol lipase from the moderately thermophilic Bacillus sp. H-257. J Biochem. 2000;127(3):419–25. 10.1093/oxfordjournals.jbchem.a022623 [DOI] [PubMed] [Google Scholar]; F1000 Recommendation
  • 54. Messia MC, Candigliota T, Marconi E: Assessment of quality and technological characterization of lactose-hydrolyzed milk. Food Chem. 2007;104(3):910–7. 10.1016/j.foodchem.2006.12.045 [DOI] [Google Scholar]
  • 55. Coker JA: Structure and function relationships in the cold-active beta-galactosidase, BgaS, examining theories of enzyme cold-adaptation. Doctoral dissertation. Penn State.2004. Reference Source [Google Scholar]
  • 56. Coker JA, Sheridan PP, Loveland-Curtze J, et al. : Biochemical characterization of a beta-galactosidase with a low temperature optimum obtained from an Antarctic Arthrobacter isolate. J Bacteriol. 2003;185(18):5473–82. 10.1128/JB.185.18.5473-5482.2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57. Sharma A, Satyanarayana T: Cloning and expression of acidstable, high maltose-forming, Ca 2+-independent α-amylase from an acidophile Bacillus acidicola and its applicability in starch hydrolysis. Extremophiles. 2012;16(3):515–22. 10.1007/s00792-012-0451-2 [DOI] [PubMed] [Google Scholar]; F1000 Recommendation
  • 58. Serour E, Antranikian G: Novel thermoactive glucoamylases from the thermoacidophilic Archaea Thermoplasma acidophilum, Picrophilus torridus and Picrophilus oshimae. Antonie Van Leeuwenhoek. 2002;81(1–4):73–83. 10.1023/A:1020525525490 [DOI] [PubMed] [Google Scholar]; F1000 Recommendation
  • 59. Han T, Zeng F, Li Z, et al. : Biochemical characterization of a recombinant pullulanase from Thermococcus kodakarensis KOD1. Lett Appl Microbiol. 2013;57(4):336–43. 10.1111/lam.12118 [DOI] [PubMed] [Google Scholar]; F1000 Recommendation
  • 60. Argüelles JC: Physiological roles of trehalose in bacteria and yeasts: a comparative analysis. Arch Microbiol. 2000;174(4):217–24. 10.1007/s002030000192 [DOI] [PubMed] [Google Scholar]
  • 61. Guo N, Puhlev I, Brown DR, et al. : Trehalose expression confers desiccation tolerance on human cells. Nat Biotechnol. 2000;18(2):168–71. 10.1038/72616 [DOI] [PubMed] [Google Scholar]
  • 62. Roberts MF: Organic compatible solutes of halotolerant and halophilic microorganisms. Saline Syst. 2005;1:5. 10.1186/1746-1448-1-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63. Littlechild JA: Archaeal Enzymes and Applications in Industrial Biocatalysts. Archaea. 2015;2015: 147671. 10.1155/2015/147671 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64. Lechevalier H: Actinomycetes and their products: a look at the future. World J Microbiol Biotechnol. 1992;8(Suppl 1):72–3. 10.1007/BF02421498 [DOI] [PubMed] [Google Scholar]
  • 65. Waksman SA, Schatz A, Reynolds DM: Production of antibiotic substances by actinomycetes. Ann N Y Acad Sci. 2010;1213:112–24. 10.1111/j.1749-6632.2010.05861.x [DOI] [PubMed] [Google Scholar]; F1000 Recommendation
  • 66. Martins MB, Carvalho I: Diketopiperazines: Biological activity and synthesis. Tetrahedron. 2007;63(40):9923–32. 10.1016/j.tet.2007.04.105 [DOI] [Google Scholar]
  • 67. Shand RF, Leyva K: Archaeal antimicrobials: an undiscovered country. In: Paul Blum ed. Archaea: new models for prokaryotic biology Norfolk, UK: Caister Academic Press,2008;233–44. [Google Scholar]
  • 68. Abed RM, Dobretsov S, Al-Fori M, et al. : Quorum-sensing inhibitory compounds from extremophilic microorganisms isolated from a hypersaline cyanobacterial mat. J Ind Microbiol Biotechnol. 2013;40(7):759–72. 10.1007/s10295-013-1276-4 [DOI] [PubMed] [Google Scholar]; F1000 Recommendation
  • 69. Kalia VC: Quorum sensing inhibitors: an overview. Biotechnol Adv. 2013;31(2):224–45. 10.1016/j.biotechadv.2012.10.004 [DOI] [PubMed] [Google Scholar]
  • 70. Stuart ES, Morshed F, Sremac M, et al. : Antigen presentation using novel particulate organelles from halophilic archaea. J Biotechnol. 2001;88(2):119–28. 10.1016/S0168-1656(01)00267-X [DOI] [PubMed] [Google Scholar]
  • 71. Stuart ES, Morshed F, Sremac M, et al. : Cassette-based presentation of SIV epitopes with recombinant gas vesicles from halophilic archaea. J Biotechnol. 2004;114(3):225–37. 10.1016/j.jbiotec.2004.01.005 [DOI] [PubMed] [Google Scholar]

Articles from F1000Research are provided here courtesy of F1000 Research Ltd

RESOURCES